Parkinson's Disease Trial, Recruiting (NCT06553625)

Parkinson's Disease Trial, Recruiting NCT06553625 Sponsor: Boston Scientific Corporation Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06553625 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You are already scheduled to be treated with a specific Boston Scientific radiofrequency system for pain or brain/nervous system conditions, as approved for use in your country
You have signed an approved consent form agreeing to take part in the study

Who may not be able to join:

You have any medical reasons that would make the Boston Scientific radiofrequency device unsafe or unsuitable for you, based on the official guidelines for that device (confirm with trial site)
You have been diagnosed with a cognitive impairment, or have any condition that might make it difficult for you to rate your pain relief or complete the study questionnaires and assessments

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Natalie M Bloom Lyons, M.A., Boston Scientific Corporation

Phone: 855-213-9890

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06553625

Sponsor: Boston Scientific Corporation

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 855-213-9890

More information: https://clinicaltrials.gov/study/NCT06553625

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You are already scheduled to be treated with a specific Boston Scientific radiofrequency system for pain or brain/nervous system conditions, as approved for use in your country
You have signed an approved consent form agreeing to take part in the study

Who may not be able to join:

You have any medical reasons that would make the Boston Scientific radiofrequency device unsafe or unsuitable for you, based on the official guidelines for that device (confirm with trial site)
You have been diagnosed with a cognitive impairment, or have any condition that might make it difficult for you to rate your pain relief or complete the study questionnaires and assessments

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Boston Scientific Corporation

Registry

ClinicalTrials.gov

Start date

29 January 2024

Est. completion

1 December 2035

Where this trial is recruiting

🇩🇪 Germany 🇬🇧 United Kingdom

Primary endpoints

Change in patient's quality of life (QoL) during the study as compared with baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov